Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Free Cash Flow (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Free Cash Flow for 16 consecutive years, with -$6.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Free Cash Flow rose 33.33% to -$6.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$24.3 million, a 10.82% increase, with the full-year FY2024 number at -$24.7 million, up 2.09% from a year prior.
  • Free Cash Flow was -$6.2 million for Q3 2025 at GeoVax Labs, down from -$4.3 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$1.3 million in Q2 2021 to a low of -$10.3 million in Q4 2023.
  • A 5-year average of -$5.1 million and a median of -$5.1 million in 2023 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: plummeted 481.76% in 2021, then soared 67.97% in 2024.
  • GeoVax Labs' Free Cash Flow stood at -$6.7 million in 2021, then fell by 5.7% to -$7.1 million in 2022, then plummeted by 45.76% to -$10.3 million in 2023, then increased by 24.7% to -$7.8 million in 2024, then rose by 19.88% to -$6.2 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Free Cash Flow are -$6.2 million (Q3 2025), -$4.3 million (Q2 2025), and -$6.0 million (Q1 2025).